What does the future hold for yellow fever virus? (II)
Klitting R., Fischer C., Doktor D. Ya. F., Gould E. A., Roiz D., Paupy C., de L. X.
Genes
Vol.9, Issue9, Num.425
Опубликовано: 2018
Тип ресурса: Обзор
Аннотация:
As revealed by the recent resurgence of yellow fever virus (YFV) activity in the tropical regions of Africa and South America, YFV control measures need urgent rethinking. Over the last decade, most reported outbreaks occurred in, or eventually reached, areas with low vaccination coverage but that are suitable for virus transmission, with an unprecedented risk of expansion to densely populated territories in Africa, South America and Asia. As reflected in the World Health Organization’s initiative launched in 2017, it is high time to strengthen epidemiological surveillance to monitor accurately viral dissemination, and redefine vaccination recommendation areas. Vector-control and immunisation measures need to be adapted and vaccine manufacturing must be reconciled with an increasing demand. We will have to face more yellow fever (YF) cases in the upcoming years. Hence, improving disease management through the development of efficient treatments will prove most beneficial. Undoubtedly,
Ключевые слова:
Emergence; Flavivirus; Vector-borne transmission; Yellow fever virus
dengue vaccine; dengvaxia; single stranded RNA; Africa; attitude to health; enhancer region; gene structure; genetic variability; geographic distribution; global health; health status; hemorrhagic fever; human; mass immunization; molecular biology; molecular diagnosis; nonhuman; patient care; practice gap; promoter region; Review; serology; South America; vector control; virus infection; virus replication; Yellow fever virus; Yellow fever virus infection
Язык текста: Английский
ISSN: 2073-4425
Klitting R.
Fischer C.
Doktor D. Ya. F. Dreksler Yan Feliks 1976-
Gould E. A.
Roiz D.
Paupy C.
de L. X. Lamballerie X.
Клиттинг Р.
Фисчер C.
Доктор Д. Я. Ф. Дрекслер Ян Феликс 1976-
Гоулд Е. А.
Роиз Д.
Паупy C.
де Л. Х. Ламбаллерие Х.
What does the future hold for yellow fever virus? (II)
Текст визуальный непосредственный
Genes
Vol.9, Issue9 Num.425
2018
Обзор
Emergence Flavivirus Vector-borne transmission Yellow fever virus
dengue vaccine dengvaxia single stranded RNA Africa attitude to health enhancer region gene structure genetic variability geographic distribution global health health status hemorrhagic fever human mass immunization molecular biology molecular diagnosis nonhuman patient care practice gap promoter region Review serology South America vector control virus infection virus replication Yellow fever virus Yellow fever virus infection
As revealed by the recent resurgence of yellow fever virus (YFV) activity in the tropical regions of Africa and South America, YFV control measures need urgent rethinking. Over the last decade, most reported outbreaks occurred in, or eventually reached, areas with low vaccination coverage but that are suitable for virus transmission, with an unprecedented risk of expansion to densely populated territories in Africa, South America and Asia. As reflected in the World Health Organization’s initiative launched in 2017, it is high time to strengthen epidemiological surveillance to monitor accurately viral dissemination, and redefine vaccination recommendation areas. Vector-control and immunisation measures need to be adapted and vaccine manufacturing must be reconciled with an increasing demand. We will have to face more yellow fever (YF) cases in the upcoming years. Hence, improving disease management through the development of efficient treatments will prove most beneficial. Undoubtedly,